AVIEW Lung Nodule CAD vs Eko Low Ejection Fraction Tool (ELEFT)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Coreline Soft
VS

AI Verdict

These two healthcare AI tools are adjacent rather than direct competitors, as they address different aspects of cardiac and pulmonary health using distinct methodologies. AVIEW Lung Nodule CAD focuses on analyzing CT scans for lung nodules, emphysema, and coronary artery calcification, primarily aiding radiologists. In contrast, the Eko Low Ejection Fraction Tool (ELEFT) integrates with digital stethoscopes to non-invasively screen for low ejection fraction, a key indicator of heart failure, during routine physical exams.

Choose AVIEW Lung Nodule CAD if…

Choose AVIEW Lung Nodule CAD if your radiology department requires advanced, AI-powered analysis of chest CT scans for comprehensive lung cancer screening and associated cardiopulmonary conditions. This tool is ideal for radiologists needing precise nodule detection, quantification, and Lung-RADS reporting, alongside quantitative emphysema and coronary artery calcification scoring from imaging data.

View AVIEW Lung Nodule CAD →

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if your clinical workflow prioritizes rapid, non-invasive screening for heart failure risk during routine physical examinations. This AI algorithm, integrated with Eko digital stethoscopes, is best suited for clinicians seeking to quickly identify patients with low ejection fraction at the point of care.

View Eko Low Ejection Fraction Tool (ELEFT) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AVIEW Lung Nodule CAD Eko Low Ejection Fraction Tool (ELEFT)
Deployment On-premises and cloud environment Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AVIEW Lung Nodule CAD

AVIEW Lung Nodule CAD offers a 'zero-click' workflow deeply integrated with PACS systems, minimizing interruptions for radiologists within their existing environment. This seamless integration for a complex imaging analysis task provides a significant usability advantage by automating data flow and presenting AI insights directly. While Eko's tool is user-friendly at the point of care, Tool A's optimization of a specialized, high-volume workflow is particularly impactful for its target users.

Clinical Value

AVIEW Lung Nodule CAD

AVIEW Lung Nodule CAD provides a comprehensive 'Big 3' analysis from a single CT scan, simultaneously screening for lung nodules (lung cancer), emphysema (COPD), and coronary artery calcification. This multi-disease detection capability offers broader diagnostic utility and efficiency compared to Eko's tool, which focuses on early detection of low ejection fraction and structural heart murmurs.

Pricing & Value

Eko Low Ejection Fraction Tool (ELEFT)

Eko Low Ejection Fraction Tool, as part of the SENSORAu2122 platform, has a clear advantage with the establishment of a Category III CPT code (0962T) and a provisional CMS reimbursement rate of $128.90 per use. This provides a transparent financial pathway for adoption and demonstrates recognized value by reimbursement bodies. Tool A's pricing remains undisclosed, making its direct value proposition harder to quantify.

Enterprise Readiness

AVIEW Lung Nodule CAD

AVIEW Lung Nodule CAD offers highly flexible deployment options including cloud, hybrid, local dedicated hardware, and local virtualized solutions, which is crucial for diverse enterprise IT infrastructures. Its deep integration with major PACS/RIS systems via a 'zero-click' workflow further enhances its readiness for large-scale radiology environments. While Tool B is an enterprise solution, its cloud-based deployment tied to specific hardware is less adaptable than Tool A's broader options.

Innovation

AVIEW Lung Nodule CAD

AVIEW Lung Nodule CAD's 'Big 3' feature, enabling simultaneous analysis of lung nodules, emphysema, and coronary artery calcification from a single CT scan, represents a significant innovative leap in comprehensive diagnostic imaging. This multi-disease screening approach maximizes the diagnostic yield and streamlines risk assessment more broadly than Tool B's point-of-care cardiac detection.

Support & Docs

Eko Low Ejection Fraction Tool (ELEFT)

Eko Health provides extensive support resources, including a dedicated Help Center with FAQs and user manuals, multiple contact options (email, scheduled calls), live demos, and an 'Eko Academy' app for clinical education and training. In contrast, no specific information regarding customer support or documentation for AVIEW Lung Nodule CAD is publicly available.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AVIEW Lung Nodule CAD Eko Low Ejection Fraction Tool (ELEFT)
Tool Name AVIEW Lung Nodule CAD Eko Low Ejection Fraction Tool (ELEFT)
Company Coreline Soft Co. Eko Health
Description AI-powered software that assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans, and offers comprehensive screening for lung cancer, COPD, and coronary artery calcification. FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
Primary Clinical Focus Lung Nodule Detection, Lung Cancer Screening, COPD, Coronary Artery Calcification Low Ejection Fraction Detection, Heart Failure Risk
Key Features AI-based pulmonary nodule detection (3-20 mm) on CT scans, Nodule classification (solid, part-solid, non-solid), 3D nodule size and volume quantification, Automatic report generation based on Lung-RADS classification, Nodule matching and volume doubling time (VDT) calculation for follow-up comparisons, Simultaneous analysis of lung nodules, emphysema, and coronary artery calcification (Big 3), Quantitative emphysema analysis (e.g., Low Attenuation Area - LAA, emphysema index), Coronary Artery Calcification (CAC) scoring (Agatston, volume, mass scores) AI-powered low ejection fraction detection, Integrates with FDA-cleared Eko digital stethoscopes, Analyzes ECG and heart sound recordings, Provides results in approximately 15 seconds, Part of the SENSORAu2122 Cardiac Early Detection Platform, Cloud-based data processing and storage, Aids in early identification of heart failure risk, Non-invasive screening tool
Specialties Cardiology, Pulmonology, Radiology Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring AVIEW Lung Nodule CAD and Eko Low Ejection Fraction Tool (ELEFT).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AVIEW Lung Nodule CAD assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans, offering comprehensive screening for lung cancer, COPD, and coronary artery calcification. The Eko Low Ejection Fraction Tool (ELEFT) aids clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
AVIEW Lung Nodule CAD analyzes chest CT scans. The Eko Low Ejection Fraction Tool (ELEFT) integrates with Eko digital stethoscopes to analyze ECG and heart sound recordings.
AVIEW Lung Nodule CAD is designed for Cardiology, Pulmonology, and Radiology specialties. Eko Low Ejection Fraction Tool (ELEFT) supports Cardiology, Family Medicine, and Internal Medicine.
AVIEW Lung Nodule CAD provides AI-based pulmonary nodule detection (3-20 mm), nodule classification (solid, part-solid, non-solid), 3D nodule size and volume quantification, automatic report generation based on Lung-RADS classification, nodule matching, volume doubling time (VDT) calculation, and simultaneous analysis of lung nodules, emphysema, and coronary artery calcification. Eko Low Ejection Fraction Tool (ELEFT) offers AI-powered low ejection fraction detection, providing results in approximately 15 seconds to aid in the early identification of heart failure risk.
AVIEW Lung Nodule CAD can be deployed locally on dedicated hardware or virtualized environments and can be linked with Picture Archiving and Communication System (PACS) by complying with DICOM standards. The Eko Low Ejection Fraction Tool (ELEFT) integrates directly with FDA-cleared Eko digital stethoscopes for data acquisition.
AVIEW Lung Nodule CAD provides comprehensive screening for lung cancer (through nodule detection and analysis), COPD (through quantitative emphysema analysis), and coronary artery calcification (through CAC scoring). The Eko Low Ejection Fraction Tool (ELEFT) specifically focuses on aiding in the early identification of low ejection fraction, which is a key indicator of heart failure.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.